Petry I - Search Results

1

A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.

Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, Boehm D, Gebhard S, Petry I, Lebrecht A, Cadenas C, Marchan R, Stewart JD, Solbach C, Holmberg L, Edlund K, Kultima HG, Rody A, Berglund A, Lambe M, Isaksson A, Botling J, Karn T, Müller V, Gerhold-Ay A, Cotarelo C, Sebastian M, Kronenwett R, Bojar H, Lehr HA, Sahin U, Koelbl H, Gehrmann M, Micke P, Rahnenführer J, Hengstler JG. Schmidt M, et al. Among authors: petry i. Clin Cancer Res. 2012 May 1;18(9):2695-703. doi: 10.1158/1078-0432.CCR-11-2210. Epub 2012 Feb 20. Clin Cancer Res. 2012. PMID: 22351685

2

ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.

Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenführer J, Maccoux L, West J, Kölbl H, Schuler M, Hengstler JG. Petry IB, et al. Clin Cancer Res. 2010 Jan 15;16(2):451-60. doi: 10.1158/1078-0432.CCR-09-1617. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068093

3

Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.

Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG. Schmidt M, et al. Breast Cancer Res Treat. 2011 Feb;125(3):637-46. doi: 10.1007/s10549-010-0856-5. Epub 2010 Mar 30. Breast Cancer Res Treat. 2011. PMID: 20352488

4

Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.

Skala CE, Petry IB, Gebhard S, Hengstler JG, Albrich SB, Maltaris T, Naumann G, Koelbl H. Skala CE, et al. Regen Med. 2009 Mar;4(2):197-204. doi: 10.2217/17460751.4.2.197. Regen Med. 2009. PMID: 19317640

5

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.

Steiner E, Pollow K, Hasenclever D, Schormann W, Hermes M, Schmidt M, Puhl A, Brulport M, Bauer A, Petry IB, Koelbl H, Hengstler JG. Steiner E, et al. Among authors: petry ib. Gynecol Oncol. 2008 Mar;108(3):569-76. doi: 10.1016/j.ygyno.2007.11.025. Epub 2008 Jan 28. Gynecol Oncol. 2008. PMID: 18222533

6

Seeger A, Kölbl H, Petry IB, Gebhard S, Battista MJ, Böhm D, Steiner E. Seeger A, et al. Among authors: petry ib. Gynecol Oncol. 2012 Apr;125(1):200-7. doi: 10.1016/j.ygyno.2011.12.443. Epub 2011 Dec 28. Gynecol Oncol. 2012. PMID: 22210468

7

The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients.

Skala CE, Petry IB, Albrich SB, Puhl A, Naumann G, Koelbl H. Skala CE, et al. Among authors: petry ib. Eur J Obstet Gynecol Reprod Biol. 2010 Nov;153(1):99-103. doi: 10.1016/j.ejogrb.2010.07.006. Epub 2010 Jul 29. Eur J Obstet Gynecol Reprod Biol. 2010. PMID: 20673608

8

The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse.

Skala CE, Petry IB, Albrich S, Puhl A, Naumann G, Koelbl H. Skala CE, et al. Among authors: petry ib. Int Urogynecol J. 2011 Jun;22(6):705-12. doi: 10.1007/s00192-010-1327-6. Epub 2010 Nov 24. Int Urogynecol J. 2011. PMID: 21107812

9

In situ co-amorphisation in coated tablets - The combination of carvedilol with aspartic acid during immersion in an acidic medium.

Petry I, Löbmann K, Grohganz H, Rades T, Leopold CS. Petry I, et al. Int J Pharm. 2019 Mar 10;558:357-366. doi: 10.1016/j.ijpharm.2018.12.091. Epub 2019 Jan 12. Int J Pharm. 2019. PMID: 30641182

10

In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium - A proof of concept study.

Petry I, Löbmann K, Grohganz H, Rades T, Leopold CS. Petry I, et al. Eur J Pharm Biopharm. 2018 Dec;133:151-160. doi: 10.1016/j.ejpb.2018.10.011. Epub 2018 Oct 16. Eur J Pharm Biopharm. 2018. PMID: 30339888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters